Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Rezolute, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- +15 vs. Q1 2025
- Shares held
- 77.9M
- +32.9M (+73.0%) vs. Q1 2025
- Total value
- $347.5M
- +$216.9M (+166.0%) vs. Q1 2025
- New holders
- 43
- 33 more added
- Sold out
- 28
- 13 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RZLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $450.3M |
| Q1 2026 | 125 | $263.2M |
| Q4 2025 | 122 | $213.4M |
| Q3 2025 | 116 | $817.1M |
| Q2 2025 | 92 | $347.5M |
| Q1 2025 | 77 | $130.6M |
| Q4 2024 | 71 | $211.7M |
| Q3 2024 | 59 | $186.9M |
| Q2 2024 | 52 | $170.0M |
| Q1 2024 | 33 | $69.0M |
| Q4 2023 | 32 | $28.7M |
| Q3 2023 | 30 | $31.5M |
| Q2 2023 | 29 | $48.0M |
| Q1 2023 | 32 | $46.5M |
| Q4 2022 | 34 | $50.6M |
| Q3 2022 | 33 | $67.0M |
| Q2 2022 | 35 | $79.2M |
| Q1 2022 | 21 | $24.0M |
| Q4 2021 | 23 | $36.0M |
| Q3 2021 | 14 | $17.6M |
| Q2 2021 | 12 | $31.6M |
| Q1 2021 | 11 | $17.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Rezolute, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −79,823−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −50,058−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −49,247−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −47,557−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −47,301−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −42,531−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −34,533−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −33,605−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −31,300−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −24,123−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −21,846−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −21,646−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −21,327−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −19,223−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −18,246−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −17,410−100.0% | Sold out |
| Jeppson Wealth Management, LLC | 0 | $0 | 0.00% | −12,001−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −11,318−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −10,779−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −3,750−100.0% | Sold out |